Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Diabetes mellitus4971 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A00012 | 35255597 | Endocrinol Metab (Seoul) | The Influence of Obesity and Metabolic Health on Vascular Health. | 2022 | Details |
| A00027 | 35250889 | Front Endocrinol (Lausanne) | Corrigendum: Pioglitazone for NAFLD Patients With Prediabetes or Type 2 Diabetes Mellitus: A Meta-Analysis. | 2022 | Details |
| A00034 | 35249505 | Curr Drug Saf | Pioglitazone, Bladder Cancer and the Presumption of Innocence. | 2022 | Details |
| A00036 | 35249342 | Ann Palliat Med | Risk factors and correlation of colorectal polyps with type 2 diabetes mellitus. | 2022 | Details |
| A00069 | 35232986 | Sci Rep | Liver injury in non-alcoholic fatty liver disease is associated with urea cycle enzyme dysregulation. | 2022 | Details |
| A00074 | 35230042 | Swiss Med Wkly | Increasing prevalence of obesity and diabetes among patients evaluated for liver transplantation in a Swiss tertiary referral center: a 10-year retrospective analysis. | 2022 | Details |
| A00080 | 35227957 | Clin Res Hepatol Gastroenterol | The impact of metabolic health on non-alcoholic fatty liver disease (NAFLD). A single center experience. | 2022 | Details |
| A00089 | 35223701 | Front Pediatr | Association Between Non-invasive Diagnostic Methods of Liver Fibrosis and Type 2 Diabetes in Pediatric Patients With Non-alcoholic Fatty Liver Disease. | 2022 | Details |
| A00118 | 35215504 | Nutrients | Dietary Patterns and Prevalent NAFLD at Year 25 from the Coronary Artery Risk Development in Young Adults (CARDIA) Study. | 2022 | Details |
| A00126 | 35212997 | Methods Mol Biol | Metabolic Phenotyping in Mice with NASH Using Indirect Calorimetry. | 2022 | Details |
| A00147 | 35208513 | Medicina (Kaunas) | Evaluation of Dose-Dependent Obesity and Diabetes-Related Complications of Water Chestnut (Fruit of Trapa japonica) Extracts in Type II Obese Diabetic Mice Induced by 45% Kcal High-Fat Diet. | 2022 | Details |
| A00158 | 35204522 | Diagnostics (Basel) | A Comparative Study of the Triglycerides/HDL Ratio and Pseudocholinesterase Levels in Patients with Bladder Cancer. | 2022 | Details |
| A00164 | 35203659 | Biomedicines | Prevalence of Pruritus and Association with Anxiety and Depression in Patients with Nonalcoholic Fatty Liver Disease. | 2022 | Details |
| A00182 | 35195697 | JAMA Netw Open | Analysis of Severe Hypoglycemia Among Adults With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease. | 2022 | Details |
| A00187 | 35193889 | BMJ Open Gastroenterol | Non-alcoholic fatty liver disease (NAFLD): a significant predictor of gestational diabetes mellitus (GDM) and early pregnancy miscarriages-prospective study in Rajarata Pregnancy Cohort (RaPCo). | 2022 | Details |
| A00188 | 35192934 | Mol Ther | Dysregulated m6A modification promotes lipogenesis and development of non-alcoholic fatty liver disease and hepatocellular carcinoma. | 2022 | Details |
| A00225 | 35176709 | Biomed Pharmacother | Purendan alleviates non-alcoholic fatty liver disease in aged type 2 diabetic rats via regulating mTOR/S6K1/SREBP-1c signaling pathway. | 2022 | Details |
| A00232 | 35173677 | Front Endocrinol (Lausanne) | Validation of Controlled Attenuation Parameter Measured by FibroScan as a Novel Surrogate Marker for the Evaluation of Metabolic Derangement. | 2022 | Details |
| A00238 | 35171411 | Med Biol Eng Comput | Exploring diet associations with Covid-19 and other diseases: a Network Analysis-based approach. | 2022 | Details |
| A00241 | 35170435 | Saudi J Gastroenterol | Correlation between serum total bile acid and nonalcoholic fatty liver disease: A cross-sectional study. | 2022 | Details |
| A00244 | 35169195 | Sci Rep | Relationship between the dynamics of non-alcoholic fatty liver disease and incident diabetes mellitus. | 2022 | Details |
| A00247 | 35167194 | J Diabetes Investig | Fatty liver with metabolic disorder, such as metabolic dysfunction-associated fatty liver disease, indicates high risk for developing diabetes mellitus. | 2022 | Details |
| A00254 | 35164079 | Molecules | Genistein-Opportunities Related to an Interesting Molecule of Natural Origin. | 2022 | Details |
| A00269 | 35159371 | Cells | The Origins of NAFLD: The Potential Implication of Intrauterine Life and Early Postnatal Period. | 2022 | Details |
| A00277 | 35154608 | Gastroenterol Hepatol Bed Bench | Assessment of common and differentially expressed proteins between diabetes mellitus and fatty liver disease: a network analysis. | 2021 | Details |
| A00279 | 35154005 | Front Endocrinol (Lausanne) | Novel Subgroups and Chronic Complications of Diabetes in Middle-Aged and Elderly Chinese:A Prospective Cohort Study. | 2022 | Details |
| A00281 | 35153138 | Hepatobiliary Pancreat Dis Int | Prevalence and characteristics of MAFLD in Chinese adults aged 40 years or older: A community-based study. | 2022 | Details |
| A00284 | 35152673 | Zhonghua Gan Zang Bing Za Zhi | [Mechanism study of the protective effects of selective cyclooxygenase-2 enzyme inhibitors on the liver of rats with type 2 diabetes mellitus combined with nonalcoholic steatohepatitis via Rho/ROCK pathway]. | 2022 | Details |
| A00300 | 35145074 | Nat Commun | Small molecule SWELL1 complex induction improves glycemic control and nonalcoholic fatty liver disease in murine Type 2 diabetes. | 2022 | Details |
| A00304 | 35144052 | Redox Biol | The role of selenium in type-2 diabetes mellitus and its metabolic comorbidities. | 2022 | Details |
| A00317 | 35140487 | Diabetes Metab Syndr Obes | The Association Between Vitamin D and Type 2 Diabetes Mellitus Complicated with Non-Alcoholic Fatty Liver Disease: An Observational Cross-Sectional Study. | 2022 | Details |
| A00319 | 35138995 | Pharm Biol | Jinlida granules ameliorate the high-fat-diet induced liver injury in mice by antagonising hepatocytes pyroptosis. | 2022 | Details |
| A00368 | 35115798 | Diabetes Metab Syndr Obes | Association of Circulating TXNIP Levels with Fatty Liver in Newly Diagnosed Type 2 Diabetes Mellitus. | 2022 | Details |
| A00379 | 35110952 | World J Gastroenterol | Non-alcoholic fatty liver disease and hepatocellular carcinoma: Clinical challenges of an intriguing link. | 2022 | Details |
| A00387 | 35107488 | Arq Bras Cir Dig | OBESITY AND SEVERE STEATOSIS: THE IMPORTANCE OF BIOCHEMICAL EXAMS AND SCORES. | 2022 | Details |
| A00388 | 35106510 | Cell Rep Med | Pegylated arginine deiminase drives arginine turnover and systemic autophagy to dictate energy metabolism. | 2022 | Details |
| A00406 | 35097198 | AACE Clin Case Rep | Biochemical and Radiological Changes in Liver Steatosis Following Mifepristone Treatment in Patients With Hypercortisolism. | 2021 | Details |
| A00407 | 35096933 | Front Nutr | Genetic and Life Style Risk Factors for Recurrent Non-alcoholic Fatty Liver Disease Following Liver Transplantation. | 2022 | Details |
| A00420 | 35091821 | Diabetologia | Adiponectin deficiency induces hepatic steatosis during pregnancy and gestational diabetes in mice. | 2022 | Details |
| A00442 | 35082753 | Front Endocrinol (Lausanne) | Triglyceride-Rich Lipoproteins and Glycoprotein A and B Assessed by 1H-NMR in Metabolic-Associated Fatty Liver Disease. | 2022 | Details |
| A00443 | 35081304 | Diabetes Metab J | Advanced Liver Fibrosis Is Associated with Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease. | 2022 | Details |
| A00447 | 35079935 | Mol Biol Rep | Physiological significance of bistable circuit design in metabolic homeostasis: role of integrated insulin-glucagon signalling network. | 2022 | Details |
| A00456 | 35075477 | Lab Med | Serum Metabolomics in Patients with Coexisting NAFLD and T2DM Using Liquid Chromatography-Mass Spectrometry. | 2022 | Details |
| A00463 | 35071254 | Front Med (Lausanne) | Not Only High Number and Specific Comorbidities but Also Age Are Closely Related to Progression and Poor Prognosis in Patients With COVID-19. | 2022 | Details |
| A00464 | 35070304 | Mol Clin Oncol | Serine palmitoyltransferase long chain subunit 3 is associated with hepatocellular carcinoma in patients with NAFLD. | 2021 | Details |
| A00466 | 35070015 | World J Hepatol | Determination of "indeterminate score" measurements in lean nonalcoholic fatty liver disease patients from western Saudi Arabia. | 2021 | Details |
| A00475 | 35068786 | J Clin Exp Hepatol | Safety and Efficacy of Saroglitazar in Nonalcoholic Fatty Liver Patients With Diabetic Dyslipidemia-A Prospective, Interventional, Pilot Study. | 2021 | Details |
| A00481 | 35066992 | Liver Int | The burden of NAFLD in type 2 diabetic subjects from the general population: A Nationwide population-based follow-up study (NASHCO). | 2022 | Details |
| A00492 | 35063496 | Diabetes Res Clin Pract | Long-term effects of the changes in hepatic steatosis status on the risk of incident type 2 diabetes mellitus: A 15-year community-based prospective cohort study. | 2022 | Details |
| A00512 | 35056346 | Medicina (Kaunas) | Colonic Diverticulosis and Non-Alcoholic Fatty Liver Disease: Is There a Connection? | 2021 | Details |
| A00513 | 35055797 | Int J Environ Res Public Health | Association of Dietary Patterns with MRI Markers of Hepatic Inflammation and Fibrosis in the MAST4HEALTH Study. | 2022 | Details |
| A00516 | 35054924 | Int J Mol Sci | GLP-1a: Going beyond Traditional Use. | 2022 | Details |
| A00527 | 35053008 | Biology (Basel) | The Snoring Index Identifies Risk of Non-Alcoholic Fatty Liver Disease in Patients with Obstructive Sleep Apnea Syndrome. | 2021 | Details |
| A00536 | 35052726 | Biomedicines | Pathophysiological Mechanisms in Non-Alcoholic Fatty Liver Disease: From Drivers to Targets. | 2021 | Details |
| A00540 | 35052597 | Antioxidants (Basel) | Gallic Acid Improves Diabetic Steatosis by Downregulating MicroRNA-34a-5p through Targeting NFE2L2 Expression in High-Fat Diet-Fed db/db Mice. | 2021 | Details |
| A00557 | 35047125 | World J Diabetes | Skeletal muscle loss is associated with diabetes in middle-aged and older Chinese men without non-alcoholic fatty liver disease. | 2021 | Details |
| A00577 | 35042213 | Pathobiology | Non-Alcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: Immunohistochemical Assessment of Markers of Cancer Cell Metabolism. | 2022 | Details |
| A00584 | 35040119 | Eur J Clin Invest | Fatty kidney: A possible future for chronic kidney disease research. | 2022 | Details |
| A00586 | 35039476 | Cell Death Dis | Pathological and therapeutic roles of bioactive peptide trefoil factor 3 in diverse diseases: recent progress and perspective. | 2022 | Details |
| A00589 | 35038311 | Eur J Endocrinol | Metformin maintains intrahepatic triglyceride content through increased hepatic de novo lipogenesis. | 2022 | Details |
| A00593 | 35036572 | Biol Methods Protoc | Preparation of fatty acid solutions exerts significant impact on experimental outcomes in cell culture models of lipotoxicity. | 2021 | Details |
| A00625 | 35024053 | Cardiovasc Ther | Serum PCSK9 Correlates with PTX3 and Apolipoproteins B, A1, and C3 Concentrations in Patients with Type 2 Diabetes. | 2021 | Details |
| A00634 | 35021057 | Immunity | Inflammation in obesity, diabetes, and related disorders. | 2022 | Details |
| A00654 | 35013596 | Nat Rev Nephrol | Association of metabolic dysfunction-associated fatty liver disease with kidney disease. | 2022 | Details |
| A00663 | 35010976 | Nutrients | Metabolic-Associated Fatty Liver Disease (MAFLD), Diabetes, and Cardiovascular Disease: Associations with Fructose Metabolism and Gut Microbiota. | 2021 | Details |
| A00676 | 35005800 | Aliment Pharmacol Ther | A sequential approach using the age-adjusted fibrosis-4 index and vibration-controlled transient elastography to detect advanced fibrosis in Korean patients with non-alcoholic fatty liver disease. | 2022 | Details |
| A00682 | 35004947 | Hepatobiliary Surg Nutr | The presence of NAFLD in nonobese subjects increased the risk of metabolic abnormalities than obese subjects without NAFLD: a population-based cross-sectional study. | 2021 | Details |
| A00690 | 35002979 | Front Endocrinol (Lausanne) | Hepatocellular Carcinoma and Obesity, Type 2 Diabetes Mellitus, Cardiovascular Disease: Causing Factors, Molecular Links, and Treatment Options. | 2021 | Details |
| A00701 | 34998036 | Int Immunopharmacol | Dapagliflozin improves steatohepatitis in diabetic rats via inhibition of oxidative stress and inflammation. | 2022 | Details |
| A00703 | 34997159 | Sci Rep | Evaluation of NAFLD fibrosis, FIB-4 and APRI score in diabetic patients receiving exenatide treatment for non-alcoholic fatty liver disease. | 2022 | Details |
| A00708 | 34993571 | Diabetologia | Dietary carbohydrate restriction augments weight loss-induced improvements in glycaemic control and liver fat in individuals with type 2 diabetes: a randomised controlled trial. | 2022 | Details |
| A00710 | 34993216 | Front Med (Lausanne) | Alterations in the Gut Microbiota and Hepatitis-B-Virus Infection in Southern Chinese Patients With Coexisting Non-Alcoholic Fatty Liver Disease and Type-2 Diabetes Mellitus. | 2021 | Details |
| A00712 | 34992579 | Front Endocrinol (Lausanne) | Association Between Diabetes Mellitus and All-Cause and Cardiovascular Mortality Among Individuals With Ultrasound-Defined Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A00744 | 34981470 | Adv Exp Med Biol | The Effect of Herbal Medicine and Natural Bioactive Compounds on Plasma Adiponectin: A Clinical Review. | 2021 | Details |
| A00747 | 34981313 | Dig Dis Sci | Bariatric Surgery in NAFLD. | 2022 | Details |
| A00748 | 34981123 | Biosci Rep | Tandem mass tag-based proteomics analysis of type 2 diabetes mellitus with non-alcoholic fatty liver disease in mice treated with acupuncture. | 2022 | Details |
| A00759 | 34977520 | JHEP Rep | Real-world management of non-alcoholic steatohepatitis differs from clinical practice guideline recommendations and across regions. | 2021 | Details |
| A00760 | 34977519 | JHEP Rep | Pegbelfermin selectively reduces secondary bile acid concentrations in patients with non-alcoholic steatohepatitis. | 2021 | Details |
| A00798 | 34962148 | Metab Syndr Relat Disord | PNPLA3 rs 738409 and Other Nongenetic Factors Associated with Hepatic Steatosis Estimated by Magnetic Resonance Imaging Proton Density Fat Fraction in Adult Greek Subjects with Type 2 Diabetes Mellitus. | 2021 | Details |
| A00806 | 34959760 | Nutrients | Blood Levels of the SMOC1 Hepatokine Are Not Causally Linked with Type 2 Diabetes: A Bidirectional Mendelian Randomization Study. | 2021 | Details |
| A00814 | 34958922 | Clin Gastroenterol Hepatol | Prevalence of High-risk Nonalcoholic Steatohepatitis (NASH) in the United States: Results From NHANES 2017-2018. | 2021 | Details |
| A00826 | 34956080 | Front Endocrinol (Lausanne) | Efficacy and Safety of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. | 2021 | Details |
| A00827 | 34955810 | Front Aging Neurosci | Liver Health and Dementia in an Italian Older Population: Findings From the Salus in Apulia Study. | 2021 | Details |
| A00830 | 34954945 | Zhonghua Wai Ke Za Zhi | [Clinical effect of minimally invasive duodenum preserving pancreatic head resection for benign and pre-malignant lesions of pancreatic head]. | 2022 | Details |
| A00834 | 34954022 | Free Radic Biol Med | Mitochondriotropic antioxidant based on caffeic acid AntiOxCIN4 activates Nrf2-dependent antioxidant defenses and quality control mechanisms to antagonize oxidative stress-induced cell damage. | 2021 | Details |
| A00837 | 34952219 | Endocr Pract | Fatty Liver Through the Ages: Nonalcoholic Steatohepatitis. | 2021 | Details |
| A00842 | 34950996 | Indian J Gastroenterol | Fetuin-A in newly detected type 2 diabetes mellitus as a marker of non-alcoholic fatty liver disease. | 2021 | Details |
| A00848 | 34950104 | Front Endocrinol (Lausanne) | Efficacy of Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Concurrent Type 2 Diabetes Mellitus and Non-Alcoholic Steatohepatitis: A Review of the Evidence. | 2021 | Details |
| A00857 | 34945016 | J Clin Med | Non-Alcoholic Fatty Liver Disease (NAFLD) and Bariatric/Metabolic Surgery as Its Treatment Option: A Review. | 2021 | Details |
| A00865 | 34944682 | Biomedicines | Metabolic Associated Fatty Liver Disease in Children-From Atomistic to Holistic. | 2021 | Details |
| A00869 | 34944525 | Biomolecules | A System-Level Mechanism of Anmyungambi Decoction for Obesity: A Network Pharmacological Approach. | 2021 | Details |
| A00879 | 34943221 | Biology (Basel) | Beta vulgaris L. (Beetroot) Methanolic Extract Prevents Hepatic Steatosis and Liver Damage in T2DM Rats by Hypoglycemic, Insulin-Sensitizing, Antioxidant Effects, and Upregulation of PPARα. | 2021 | Details |
| A00885 | 34941988 | J Gastrointestin Liver Dis | The Role of Psychotherapy in the Treatment of Patients with Non- alcoholic Fatty Liver Disease and Obstructive Sleep Apnea. | 2021 | Details |
| A00893 | 34938631 | Cureus | Glycogenic Hepatopathy as the Etiology of Abnormal Liver Chemistries in an Uncontrolled Type I Diabetic Patient. | 2021 | Details |
| A00897 | 34938090 | Diabetes Metab Syndr Obes | The Predictive Ability of Hepatic Steatosis Index for Gestational Diabetes Mellitus and Large for Gestational Age Infant Compared with Other Noninvasive Indices Among Chinese Pregnancies: A Preliminary Double-center Cohort Study. | 2021 | Details |
| A00901 | 34934197 | Acta Pharmacol Sin | GLP-1 mimetics as a potential therapy for nonalcoholic steatohepatitis. | 2021 | Details |
| A00902 | 34934162 | Sci Rep | Liver fibrosis indices are related to diabetic peripheral neuropathy in individuals with type 2 diabetes. | 2021 | Details |
| A00916 | 34931080 | Nat Metab | Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity. | 2021 | Details |
| A00926 | 34927282 | Drug Dev Res | Schisandrin B ameliorates non-alcoholic liver disease through anti-inflammation activation in diabetic mice. | 2021 | Details |
| A00939 | 34923473 | Wiad Lek | FEASIBILITY OF CYSTATIN C DETERMINATION FOR EARLY DIAGNOSIS OF KIDNEY DAMAGE IN PATIENTS WITH TYPE 2 DIABETES COMBINED WITH NONALCOHOLIC FATTY LIVER DISEASE AND OBESITY EXPOSED TO COVID-19 INFECTION IN THE PAST. | 2021 | Details |